Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.825
Bid: 5.60
Ask: 6.20
Change: 0.00 (0.00%)
Spread: 0.60 (10.714%)
Open: 5.825
High: 0.00
Low: 0.00
Prev. Close: 5.825
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Licensing Agreement

19 Sep 2005 07:02

Plant Health Care PLC19 September 2005 Embargoed until 7am 19 September 2005 Plant Health Care plc License Agreement Plant Health Care ("PHC" or the "Group") is pleased to announce that it hasentered into a licensing agreement with Eden Bioscience for the use of Eden'snext generation Harpin technology. Harpins are proteins that elicit a growthresponse when applied to plants. Under the terms of the agreement PHC will haveexclusive rights for a minimum of 5 years (subject to minimum purchaserequirements) to use Harpin technology in nutritional products in the UK, theNetherlands and Scandinavia, and non-exclusive rights to sell those products inNorthern Africa and Italy. PHC has the right to test these products in Mexicoand the US to determine their market potential. PHC has developed a product trademarked Pre-Tect which combines Harpin withsome of PHC's proprietary natural based technologies. In trials, Pre-Tect hasbeen shown to consistently increase the yield and the shelf life of leaf crops,such as lettuce, spinach and broccoli, for 2 to 5 days. The Group is currently in discussions with certain supermarket chains in the UKconcerning the possibility of Pre-Tect being used by their growers and suppliersin order to reduce their product wastage. John Brady, CEO of Plant Health Care, said, "The incorporation of Eden's nextgeneration Harpin technology into PHC's product portfolio is a very excitingaddition for the Group. Our Pre-Tect product has consistently increased yieldand shelf life on leaf crops and by using Pre-Tect as one of their regularcropping inputs grocers can address one of the most significant problems thatthey face, namely the limited shelf life of fresh produce. PHC'S Pre-Tect willallow the grocers to naturally add shelf life, limit losses due to spoilage and,as a result, increase profits. For further information please contact: Plant Health Care plcJohn Brady, CEO Tel: 001 603 525 3702 Eden BioscienceRhett Atkins, CEO Tel: 001 425 806 7300 Tavistock Communications Tel: 020 7920 3150Jeremy CareyChristian Taylor-Wilkinson Notes to Editors: About Plant Health CarePlant Health Care plc ("PHC") is a leading provider of natural products forplants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the UnitedStates, PHC currently has approximately 60 employees and has operations in theUS, Mexico, UK, Spain, and the Netherlands with technical support in Austria.The Group has two principal operating subsidiaries in the US - PHC Inc (PA) andPHC-REC. The Company listed on the AIM market of the London Stock Exchange inJuly 2004. Ticker symbol is phc. PHC's products are aimed at the horticulture, agriculture, turf grass,commercial landscaping, forestry and land reclamation industries and are bothenvironmentally beneficial and on the whole more cost effective than syntheticchemical alternatives. Through the commercialisation of these products, PHC iscapitalising on current long-term trends toward natural systems and biologicalproducts for plant care and soil and water management uses. PHC-REC is an environmental and reclamation engineering consulting firm whichprovides engineering and design services for reclamation lands disturbed bymining, construction, and other activities. PHC-REC is the recognised leader inthe use of biologically based solutions using mycorrhizal fungi and bacteria forthe establishment of trees, shrubs, and grasses on these disturbed lands.PHC-REC was established in 1997 to exploit PHC's products and technology. Web Site: www.planthealthcare.com About Eden Bioscience Eden Bioscience was founded in 1994 and is located in Bothell, Washington USA.The company is primarily engaged in the sales and marketing of its proprietaryHarpin technology. Eden's technology is based on a family of naturally occurringproteins called "harpins" and represents a unique type of crop production toolEden classifies as plant health regulators. Web site: www.edenbio.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
16th May 20242:24 pmRNSHolding(s) in Company
14th May 20242:58 pmRNSHolding(s) in Company
8th May 20247:00 amRNSTrading Update
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.